搜索结果


   KDM4A

靶点ID:TCMBANKGE012961


靶点别名:JHDM3A; JMJD2; JMJD2A; TDRD14A


靶点描述:lysine demethylase 4A


染色体:1


染色体位置:1p34.2-p34.1


靶点类型:protein-coding


HERB_ID:-


HGNC_Link:22978


OMIM_Link:609764


Ensembl_Link:ENSG00000066135


   靶点对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族

   靶点对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN002276 aminozide B 995; SBB057747; 6853-EP2295550A2; 26949-EP2305658A1; 6853-EP2305260A1; Succinic acid-2,2-dimethylhydrazide; LS-908; 3-[N-(dimethylamino)carbamoyl]propanoic acid; Butanedioic acid mono(2,2-dimethylhydrazide); Aminozid; N-Dimethylamino-succinamidsaeure; SCHEMBL50347; diaminozide; SUCCINIC ACID, 2,2-DIMETHYLHYDRAZIDE; Daminozide [ANSI:BSI:ISO]; AK310838; 1-(2,2-Dimethylhydrazide)butanedioic acid; N-Dimethylamino-beta-carbamylpropionic acid; N-dimethylamino-beta-carbamyl propionic acid; D4015; NCGC00091281-03; B-Nine; Alar 85; 74913-15-8; MFCD00002787; 6853-EP2275425A1; 6853-EP2301934A1; MolPort-002-927-289; EINECS 216-485-9; NCGC00091281-04; 3-(N',N'-dimethylhydrazinecarbonyl)propanoic acid; K-5005; W-107985; 6853-EP2371808A1; AC1L25O2; 4-(2,2-Dimethylhydrazino)-4-oxobutanoic acid; N-dimethylamino-beta-car bamyl propionic acid; AI3-50727; Succinic 1,1-dimethyl hydrazide; FT-0629276; D0B2WZ; Succinic acid, mono(2,2-dimethylhydrazide); EPA Pesticide Chemical Code 035101; NCGC00259748-01; AN-49511; MCULE-6532969482; AKOS005208038; DMASA; Kylar; NINE; 6853-EP2298760A1; Dazide; N-Dimethylamino-succinamidsaeure [German]; NCGC00091281-01; DSSTox_CID_370; CCG-55990; DYaK; NCGC00254822-01; Daminozide (B9); alar-85; NCI-C03827; 6853-EP2275420A1; 6853-EP2308882A1; 6853-EP2272516A2; Dimethylaminosuccinamic acid; CHEMBL2164243; 6853-EP2308875A1; micro yen(2,2- paragraph signthorn(1/4)x>>uo poundeA) paragraph sign inverted exclamation mark paragraph signthornEao poundeA; 6853-EP2305686A1; SMR000777919; 1596-84-5; Succinic Acid, N,N-dimethylhydrazide; AB0018582; NCGC00091281-05; 26949-EP2314583A1; DAMINOZIDE (DIMETHYLAMINOSUCCINAMIC ACID); DSSTox_RID_75546; NCGC00091281-07; 6853-EP2292613A1; C10996; Daminozide, PESTANAL(R), analytical standard; 6853-EP2292612A2; 4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid; CCRIS 191; ST50308567; Jsp003172; HY-13643; 6853-EP2274983A1; Succinic N',N'-dimethylhydrazide; Succinic acid N,N-dimethylhydrazide; CHEBI:4312; SR-01000644985-1; Succinic acid 2,2-dimethylhydrazide; Bernsteinsaeure-2,2-dimethylhydrazid [German]; ALAR; 6853-EP2289892A1; 4-(2,2-Dimethylhydrazino)-4-oxobutanoic acid #; Butanedioic acid, mono(2,2-dimethylhydrazide); BDBM50395076; DTXSID9020370; NOQGZXFMHARMLW-UHFFFAOYSA-N; Succinic acid, mono-2,2-dimethylhydrazine; Dimas; 6853-EP2316836A1; Caswell No. 808; BRN 1863230; ZINC1532111; Tox21_202199; CS-1288; 4-(2,2-dimethylhydrazino)-4-oxo-butanoic acid; NCGC00091281-02; F6KF33M5UB; HSDB 1769; Aminozide; N-(Dimethylamino)succinamic acid; CAS-1596-84-5; UNII-F6KF33M5UB; Succinic acid mono-(2,2-dimethylhydrazide); SADH; Succinic acid mono(2,2-dimethylhydrazide); 6853-EP2292615A1; 6853-EP2308865A1; Daminozide; MLS006012018; S346; 2,2-Dimethylhydrazid kyseliny jantarove [Czech]; 26949-EP2371823A1; Bernsteinsaeure-2,2-dimethylhydrazid; 6853-EP2277879A1; 1861-26-3; DSSTox_GSID_20370; 2,2-Dimethylhydrazid kyseliny jantarove; Tox21_300919; GTPL7025 C6H12N2O3 160.17 g/mol CN(C)NC(=O)CCC(=O)O
TCMBANKIN043561 Laminine AC1L98PS; FT-0695852; delta-trimethyllysine; N-EPSILON,N-EPSILON,N-EPSILON-TRIMETHYLLYSINE; S)-5-amino-5-carboxy-N,N,N-trimethyl-1-pentanaminium; 23284-33-5; Trimethyllysine; (S)-2-amino-6-(trimethylammonio)hexanoic acid; C-53472; C03793; AKOS006272412; N6,N6,N6-Trimethyl-L-lysine; N(6),N(6),N(6)-trimethyl-L-lysine; (S)-2-amino-6-(trimethylammonio)hexanoate; (2S)-2-amino-6-(trimethylazaniumyl)hexanoate 189.28 g/mol
TCMBANKIN057905 ferrum iron Fe 55.84 g/mol [Fe]

   靶点对应的疾病
疾病ID 疾病名 MeSH名 HPO名 UMLS名 疾病类型
TCMBANKDI000009 Neoplasms Abnormality of the nervous system; Neoplasm Neoplastic Process disease
TCMBANKDI000018 Digestive System Diseases; Neoplasms; Endocrine System Diseases Abnormality of the digestive system; Neoplasm Neoplastic Process disease
TCMBANKDI000054 Nervous System Diseases; Mental Disorders Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI000076 Neoplasms - Neoplastic Process group
TCMBANKDI003353 Pathological Conditions, Signs and Symptoms; Neoplasms - Neoplastic Process phenotype
TCMBANKDI006612 Neoplasms; Female Urogenital Diseases and Pregnancy Complications Abnormality of the genitourinary system; Neoplasm Neoplastic Process disease
TCMBANKDI010395 Neoplasms - Neoplastic Process disease
TCMBANKDI011743 Neoplasms; Skin and Connective Tissue Diseases Neoplasm; Abnormality of the breast Neoplastic Process group
TCMBANKDI011758 - - Laboratory Procedure phenotype
TCMBANKDI011883 - - Mental Process phenotype
TCMBANKDI012986 Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases - Disease or Syndrome disease
TCMBANKDI014817 - - Neoplastic Process disease
TCMBANKDI015336 - - Disease or Syndrome phenotype
TCMBANKDI016026 Neoplasms; Eye Diseases Neoplasm; Abnormality of the eye Neoplastic Process disease
TCMBANKDI017024 Neoplasms; Respiratory Tract Diseases - Neoplastic Process disease
TCMBANKDI017642 Neoplasms Abnormality of the integument; Neoplasm Neoplastic Process disease
TCMBANKDI024535 Neoplasms; Respiratory Tract Diseases Neoplasm; Abnormality of the respiratory system Neoplastic Process disease
TCMBANKDI025420 Digestive System Diseases; Neoplasms Abnormality of the digestive system; Neoplasm Neoplastic Process disease